GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Accounts Payable & Accrued Expense

NKGen Biotech (NKGen Biotech) Accounts Payable & Accrued Expense : $14.58 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Accounts Payable & Accrued Expense?

NKGen Biotech's quarterly accounts payable & accrued expense increased from Sep. 2023 ($12.40 Mil) to Dec. 2023 ($12.69 Mil) and increased from Dec. 2023 ($12.69 Mil) to Mar. 2024 ($14.58 Mil).

NKGen Biotech's annual accounts payable & accrued expense declined from Dec. 2021 ($3.83 Mil) to Dec. 2022 ($2.36 Mil) but then increased from Dec. 2022 ($2.36 Mil) to Dec. 2023 ($12.69 Mil).

NKGen Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for NKGen Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Accounts Payable & Accrued Expense Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
3.83 2.36 12.69

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial 2.36 - 12.40 12.69 14.58

NKGen Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.